search
Back to results

Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer

Primary Purpose

Corneal Ulcer

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
acellular corneal matrix
Sponsored by
Shaanxi Aierfu Activtissue Engineering
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Corneal Ulcer

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged between 18 and 75 yrs.
  • Corneal ulcer.
  • Informed consent.

Exclusion Criteria:

  • Corneal perforation.
  • Other ocular diseases.
  • The presence of systemic connective tissue diseases
  • Severe allergic constitution
  • Pregnancy
  • The presence of chronic disease, such as significant cardiovascular illness
  • The patients who received clinical experiments for other medicine or medical devices within 3 months prior to the transplantation.
  • Any patient that is not suitable for recruitment, in the judgment of the investigator.

Sites / Locations

  • Beijing Tongren HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Acellular corneal matrix

Arm Description

Outcomes

Primary Outcome Measures

Rejection evaluation

Secondary Outcome Measures

Corneal wound healing

Full Information

First Posted
November 18, 2010
Last Updated
May 5, 2011
Sponsor
Shaanxi Aierfu Activtissue Engineering
Collaborators
Shenzhen AiNear Cornea Engineering Company Limited, Air Force Military Medical University, China, Engineering Technology Center for Tissue Engineering of Xi'an, Beijing Tongren Hospital, West China Hospital, Henan Provincial People's Hospital, Wuhan Union Hospital, China, Southwest Hospital, China
search

1. Study Identification

Unique Protocol Identification Number
NCT01244776
Brief Title
Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer
Official Title
Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Unknown status
Study Start Date
April 2010 (undefined)
Primary Completion Date
December 2011 (Anticipated)
Study Completion Date
July 2012 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Shaanxi Aierfu Activtissue Engineering
Collaborators
Shenzhen AiNear Cornea Engineering Company Limited, Air Force Military Medical University, China, Engineering Technology Center for Tissue Engineering of Xi'an, Beijing Tongren Hospital, West China Hospital, Henan Provincial People's Hospital, Wuhan Union Hospital, China, Southwest Hospital, China

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is to develop a lamellar keratoplasty method for corneal ulcer using acellular corneal matrix (ACM) and to make an analysis among patients for its therapeutic effect.
Detailed Description
Infections, chemical injury, and other diseases result in acute or chronic corneal ulcer, which may damage corneal stroma and may lead to permanent corneal scars and blindness. Corneal transplantation is standard method for corneal ulcer, but severe shortage of donor corneas limits its application. Acellular porcine corneal matrix is similar to the native cornea, especially with the biological property and microstructure. Recently, this matrix has been proved to be safe when transplanted to animal subjects and will not be rejected by the recipient. In animal lamellar keratoplasty experiments, acellular corneal matrix showed that they can integrate into the corneal wound bed and help reconstruction of the lamellar integrity of corneal stroma. This study will investigate its healing effect on human corneal ulcer. It will provide a potential corneal substitute for this disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Corneal Ulcer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Acellular corneal matrix
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
acellular corneal matrix
Other Intervention Name(s)
ACM
Intervention Description
Efficacy of acellular corneal matrix to restore stroma integrity and treat corneal ulcer after lamellar keratoplasty.
Primary Outcome Measure Information:
Title
Rejection evaluation
Time Frame
30 days following transplantation
Secondary Outcome Measure Information:
Title
Corneal wound healing
Time Frame
90 days following transplantation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged between 18 and 75 yrs. Corneal ulcer. Informed consent. Exclusion Criteria: Corneal perforation. Other ocular diseases. The presence of systemic connective tissue diseases Severe allergic constitution Pregnancy The presence of chronic disease, such as significant cardiovascular illness The patients who received clinical experiments for other medicine or medical devices within 3 months prior to the transplantation. Any patient that is not suitable for recruitment, in the judgment of the investigator.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yongbo Lu
Phone
86-29-84776153
Email
yongerbo@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liuhe Zhou, M.D.
Organizational Affiliation
Beijing Tongren Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beijing Tongren Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100730
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Liuhe Zhou

12. IPD Sharing Statement

Learn more about this trial

Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer

We'll reach out to this number within 24 hrs